98 results
8-K
EX-10.1
ADIL
Adial Pharmaceuticals Inc
6 Mar 24
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
4:21pm
8-K
EX-10.2
ADIL
Adial Pharmaceuticals Inc
18 Jan 24
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
4:15pm
8-K
EX-10.1
ADIL
Adial Pharmaceuticals Inc
6 Nov 23
Departure of Directors or Certain Officers
6:14am
8-K
EX-10.1
ADIL
Adial Pharmaceuticals Inc
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm
8-K
EX-10.2
ADIL
Adial Pharmaceuticals Inc
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm
8-K
EX-10.1
2ve9sl8
2 Jun 23
Entry into a Material Definitive Agreement
6:02am
8-K
EX-10.1
kw27 kzh5
21 Mar 23
Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder
9:15am
8-K
EX-10.3
zzbq 71n4
24 Feb 23
Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering
9:00am
8-K
EX-10.1
er3l7kqic5e0wb
24 Feb 23
Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering
9:00am
8-K
EX-10.2
aopseue841zy 39e6w4v
24 Feb 23
Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering
9:00am
8-K
EX-10.1
rhvvo l4xexh9aei
1 Feb 23
Adial Pharmaceuticals Enters Into Option Agreement
4:13pm
8-K
EX-10.1
oq8n6iu57fsvldl2ti
13 Oct 22
Departure of Directors or Certain Officers
4:56pm
8-K
EX-10.1
6ym1ibnwjhqe
13 Sep 22
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.1
ngsbm
23 Aug 22
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.2
60je6bv3bufzg1v
23 Aug 22
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.1
ot5rpifl8za 2xz
14 Feb 22
Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering
5:11pm
8-K
EX-10.2
27gc6 2sbo
14 Feb 22
Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering
5:11pm
8-K
EX-10.1
4d6gzr w3
9 Dec 21
Adial Announces Cary J. Claiborne, a Renowned Pharmaceutical Executive and Current Board Member, has Joined the Company as Chief Operating Officer
9:29am
8-K
EX-10.1
zhr8c0qd1t wo
12 Nov 21
Adial Pharmaceuticals Announces Private Placement of Common Stock at $4.00 Per Share
9:00am